Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.
Article Details
- CitationCopy to clipboard
Kast RE, Focosi D, Petrini M, Altschuler EL
Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.
Bone Marrow Transplant. 2007 Jun;39(12):811-2. Epub 2007 Apr 23.
- PubMed ID
- 17450180 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Ziprasidone 5-hydroxytryptamine receptor 2A Protein Humans YesAntagonistDetails